bioAffinity Technologies prices $3.2 million public offering

bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) has priced a public offering of securities for aggregate gross proceeds of $3.2 million, before deducting agent fees and other estimated expenses, according to a press release from the San Antonio-based biotechnology company.

The offering consists of 4,000,000 shares of common stock at a purchase price of $0.80 per share, with a par value of $0.007 per share. Pre-funded warrants may be issued in lieu of shares at a price of $0.793 per warrant, with each warrant exercisable for one share of common stock. The warrants are immediately exercisable and expire upon full exercise.

The closing of the offering is expected to occur on or about June 18, 2026, subject to customary closing conditions. WallachBeth Capital, LLC is acting as sole placement agent.

The securities are being offered pursuant to a registration statement on Form S-1 previously filed and declared effective by the Securities and Exchange Commission.

You May Also Be Interested In

• bioAffinity Technologies closes $3.2M public offering
• Hamilton Beach Brands senior VP and general counsel departs
• Senti Biosciences (SNTI) files for 15.97M share offering by selling stockholders